This website uses cookies to store information on your computer. Some of these cookies are used for visitor analysis, others are essential to making our site function properly and improve the user experience. By using this site, you consent to the placement of these cookies. Click Accept to consent and dismiss this message or Deny to leave this website. Read our Privacy Statement for more.
Join Mailing List   |   Jobs   |   Print Page   |   Contact Us   |   Sign In   |   Join
News & Press: ISTH News

New Recommendations on Standardization of Testing for Drug-Induced Immune Thrombocytopenia

Friday, January 23, 2015   (0 Comments)
Share |

The Journal of Thrombosis and Haemostasis (JTH) has accepted the following article on recommendations from the Platelet Immunology Subcommittee of the Scientific and Standardization Committee (SSC):

Recommendations for Standardization of Laboratory Testing for Drug-Induced Immune Thrombocytopenia
Drug-induced immune thrombocytopenia (DITP) is a life-threatening clinical syndrome that is
under-recognized and difficult to diagnose. Clinical criteria can help determine the
likelihood that a drug was the cause of thrombocytopenia but confirmation of the diagnosis
requires laboratory testing to demonstrate the presence of drug-dependent platelet
antibodies. There is a need to improve accessibility of testing for the most commonly implicated drugs,
which means that the methods of testing including, sample collection, handling of target
platelets, drug concentrations, and the type of immunoassay should be standardized. 


View the accepted article for this topic from the JTH here.

Membership Management Software Powered by YourMembership  ::  Legal